A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+34.99%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$292M
AUM Growth
+$292M
Cap. Flow
-$101M
Cap. Flow %
-34.54%
Top 10 Hldgs %
96.78%
Holding
22
New
1
Increased
Reduced
1
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$100M 34.21% 4,168,718
VERA icon
2
Vera Therapeutics
VERA
$1.38B
$63.1M 21.57% 2,960,231
HLVX icon
3
HilleVax
HLVX
$105M
$31.4M 10.74% 1,838,486
ACET icon
4
Adicet Bio
ACET
$59.9M
$30M 10.26% 2,115,385
VRNA
5
Verona Pharma
VRNA
$9.16B
$25.1M 8.58% 2,457,500
PHAT icon
6
Phathom Pharmaceuticals
PHAT
$864M
$15.9M 5.44% 1,435,106
OKUR
7
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$6.95M 2.38% 2,073,957
JSPR icon
8
Jasper Therapeutics
JSPR
$45.5M
$4.44M 1.52% 5,628,558
NCNA
9
NuCana
NCNA
$6.09M
$3.4M 1.16% 3,333,333
EFTR
10
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2.73M 0.93% 4,822,114
PRTK
11
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.68M 0.91% 1,041,131
SPRB
12
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$2.47M 0.85% +1,792,518 New +$2.47M
SLNO icon
13
Soleno Therapeutics
SLNO
$3.6B
$2.01M 0.69% 1,201,506 -16,821,096 -93% -$28.1M
SIEN
14
DELISTED
Sientra, Inc.
SIEN
$1.07M 0.37% 1,673,589
CBAY
15
DELISTED
Cymabay Therapeutics
CBAY
$457K 0.16% 131,036
XCUR icon
16
Exicure
XCUR
$35.4M
$439K 0.15% 281,636
MTEM
17
DELISTED
Molecular Templates, Inc.
MTEM
$150K 0.05% 200,000
SYRE icon
18
Spyre Therapeutics
SYRE
$996M
$127K 0.04% 240,500
OBSV
19
DELISTED
ObsEva SA Ordinary Shares
OBSV
$13K ﹤0.01% 87,999
OCGN icon
20
Ocugen
OCGN
$319M
-7,111 Closed -$16K
SRRA
21
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-1,314,127 Closed -$72.3M